Many people begin to notice reduced pain and improved joint function within 2 to 4 weeks of starting BPC-157
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Subcutaneous (SC) : Common sites include the upper arm, thigh, or abdomen
Vitamin shots arent just for people who feel sluggish
So, if you're considering giving B12 shots a try, why not explore the options available at ThinWorks
This is a paid advertisement and does not necessarily reflect the official policy or position of the Times Standard, its employees, or subsidiaries.